BOT 6.25% 34.0¢ botanix pharmaceuticals ltd

Ann: New Antimicrobial Data and Conference Presentation, page-27

  1. 518 Posts.
    lightbulb Created with Sketch. 257
    Hi Gumnut1,
    This is an exciting video. Vince is a wonderful presenter and you can’t help but feel like great things are about to happen with all the current streams of activity, being anti-microbial, acne and rosacea.
    Anti-microbial alone - based on existing testing outcomes and the evidence presented - looks like being a huge success. And, we should have further results from current phase 2a testing before the end of this year. Not too long to wait. This has got success written all over it. Although I remember saying the same about Acne Phase 2 and Dermatitis testing.
    If it is successful, the market for the resultant product range is absolutely huge and will deliver us SHs some significant sp growth. I certainly hope so, as my current significant investment in Bot is well and truely in red after the acne and dermatitis outcomes. I an sure many other SHs are in the same position.
    Add Acne phase 3 and Rosacea to the anti-microbial platform and the future looks bright.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.020(6.25%)
Mkt cap ! $615.4M
Open High Low Value Volume
32.0¢ 34.0¢ 32.0¢ $1.776M 5.339M

Buyers (Bids)

No. Vol. Price($)
1 118187 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 698385 8
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.